Skip to main content
. 2017 Sep 23;8(49):86515–86526. doi: 10.18632/oncotarget.21230

Figure 3. Relationship of the DRD2 mRNA levels with the severity of deficit syndrome in chronic schizophrenia patients.

Figure 3

In chronic schizophrenia patients, a significant relationship was detected only between the mRNA expression levels of DRD2 (r=0.511, p=0.025) and the Proxy for the Deficit Syndrome (PDS) score.